PMV Pharmaceuticals, Inc. (PMVP) Financials
PMVP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 252.2 million | 26.5 million |
2023-09-30 | 261.0 million | 23.4 million |
2023-06-30 | 242.2 million | 24.4 million |
2023-03-31 | 254.0 million | 23.8 million |
PMVP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -12.3 million | 3.0 million |
2023-09-30 | -15.7 million | 3.3 million |
2023-06-30 | -13.5 million | 3.2 million |
2023-03-31 | -15.2 million | 2.9 million |
PMVP Net Income
No data available :(
PMVP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 203.9 million | - | 13.3 million |
2023-09-30 | 201.9 million | - | 12.7 million |
2023-06-30 | 187.1 million | - | 13.0 million |
2023-03-31 | 229.4 million | - | 13.5 million |
PMVP Shares Outstanding
PMVP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 197000 | 13.0 million | 5.5 million | - |
2023-09-30 | 44000 | 13.6 million | 6.0 million | - |
2023-06-30 | 565000 | 13.8 million | 6.3 million | - |
2023-03-31 | 156000 | 15.1 million | 6.4 million | - |
PMVP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.6 million | 359000 |
2023-09-30 | - | 358000 |
2023-06-30 | - | 369000 |
2023-03-31 | - | 82000 |
PMVP
Price: $1.87
52 week price:
Earnings Per Share: -1.44 USD
P/E Ratio: -1.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 230900
Market Capitalization: 82.3 million